Precision Biology™ Services

Your Study. Our Expertise.
Results You Can Trust.

Accelerate your biomarker programs with custom assay development, clinical trial testing, and expert analysis – powered by industry-leading spatial biology and liquid biopsy platforms from RareCyte.

Request a consultation

Pharma clients served

Clinical trials supported

Custom assays developed

Years of platform experience

Our Services

From sample receipt through staining, imaging, and data delivery, we manage the full workflow with scientific rigor and quality standards built for clinical programs.

Spatial Biology Services

The Orion spatial proteomics platform delivers the multiplex depth, throughput, and reproducible data quality clinical researchers need to advance precision medicine programs.

Panel Development – Panel design and optimization tailored to your custom biomarkers and tissue type
Panel Transfer – Reproducibility package delivered to your lab or your CRO partner
Clinical Sample Testing and Analysis – Performed under pathologist guidance with customizable analysis and reporting

Learn more about the Orion platform

Liquid Biopsy Services

The CyteFinder platform enables high-sensitivity detection, phenotyping, and analysis of circulating tumor cells (CTCs) and other rare cells from liquid biopsy samples.

Assay Development – Custom assays for detecting drug target and pharmacodynamic biomarkers expressed by ultra-rare cells in blood
Assay Transfer – Performance and reproducibility confirmed with your CRO partner
Clinical Sample Testing and Analysis – Track patient response to therapy in global clinical trials

Learn more about the CyteFinder platform

Who we work with

We deliver end-to-end services — from custom assay development to clinical trial testing — for researchers, translational scientists, drug development and CRO organizations. Whether you need to develop your first liquid biopsy assay or spatial biology panel, or are running samples for a global trial, our team brings the platform expertise and scientific rigor to get you there.

“The RareCyte CTC system has been analytically validated in our CAP/CLIA Laboratory and the validation and acceptance criteria met the needs of the clinical drug study team. In partnership with a global CRO, the CTC workflow is being successfully implemented.”

Jeff Fill

Sr. Director, Diagnostic and Experimental Pathology | Eli Lilly and Company

Why RareCyte

You're not just buying a service. You're gaining a scientific partner.

Deep Platform Expertise

Industry-leading Orion and CyteFinder platforms were invented here. That means when you work with RareCyte, you have the world experts running your program.

Trusted Partner

A proven partner to over 100 biopharma and leading academic institutions, delivering hundreds of custom assays to support biomarker development across diverse indications.

Responsive at Every Stage

From contracting through data delivery, we provide clear, timely communication. When questions arise, you have direct access to the scientific team delivering your program results.

Focused on Your Deadlines

Clinical programs run on tight timelines. We do too. Our team is structured to meet client deadlines — and when plans shift, we adapt quickly.

Accredited Infrastructure

To meet the quality requirements of our customers, the RareCyte quality management system includes an accredited CLIA Laboratory following GLP guidelines, LIMS and eQMS systems for sample and documentation management, along with an ISO13485:2016 accreditation for product manufacturing.

“Using their liquid biopsy technology, RareCyte was able to develop a custom assay. Throughout the process, the RareCyte team was collaborative and insightful, showing true dedication to the project, resulting in the development of a fully validated assay.”

Erica Tobin

Associate Director, Oncology | KSQ Therapeutics, Inc.

Qualified Service Providers

Access RareCyte platforms wherever your research is based.

Our global network of Qualified Service Providers (QSPs) delivers the same validated Orion and CyteFinder workflows — trained and certified directly by RareCyte — at institutions and research organizations worldwide. We work closely in partnership with our partners to ensure the success of your study.